CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Erin Wright from ...

Witnessing a positive shift, the current average has risen by 6.25% from the previous average price target of $64.00. A clear picture of CVS Health's perception among financial experts is painted ...

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

CVS Health shows signs of recovery and growth potential. Learn why CVS stock is a buy with improved cash flow and strong ...

CVS Health reported mixed third-quarter results as higher medical ... insulin prices Pfizer says drug for deadly cancer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health (CVS) is expected to deliver a year-over-year decline ... it's worth having a handicapping insight into the odds of a positive EPS surprise. This drugstore chain and pharmacy benefits ...